Articles tagged with "U.S. Food and Drug Administration (FDA)"

FDA Warning: Avoid Use of NSAIDs after Week 20 of Pregnancy

October 28, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

October 21, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA

October 9, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

October 7, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

U.S. & E.U. Differ on Filgotinib for RA

September 14, 2020 • By Michele B. Kaufman, PharmD, BCGP

ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner

August 10, 2020 • By From the College

Guselkumab Approved for PsA

August 6, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis

August 5, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis

July 15, 2020

1
2
3
…
9
Next Page »